LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 106 of 166
Next
>>
>
2626 to 2650 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Y39983	1.11	uM	LJP6	72	hr	1334	3860	3925	0.9833	0.9784
BT-20	Y39983	3.33	uM	LJP6	72	hr	1334	3643	3925	0.9282	0.9063
BT-20	Y39983	10	uM	LJP6	72	hr	1334	2476	3925	0.6310	0.4876
BT-20	Nintedanib	0.04	uM	LJP6	72	hr	1334	4047	3925	1.0311	1.0391
BT-20	Nintedanib	0.12	uM	LJP6	72	hr	1334	4041	3925	1.0295	1.0373
BT-20	Nintedanib	0.37	uM	LJP6	72	hr	1334	3517	3925	0.8962	0.8628
BT-20	Nintedanib	1.11	uM	LJP6	72	hr	1334	3668	3925	0.9345	0.9139
BT-20	Nintedanib	3.33	uM	LJP6	72	hr	1334	2894	3925	0.7375	0.6445
BT-20	Nintedanib	10	uM	LJP6	72	hr	1334	2846	3925	0.7251	0.6262
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1334	3950	4033	0.9791	0.9732
BT-20	Foretinib	0.12	uM	LJP5	72	hr	1334	2941	4033	0.7297	0.6414
BT-20	Foretinib	0.37	uM	LJP5	72	hr	1334	1368	4033	0.3395	0.0159
BT-20	Foretinib	1.11	uM	LJP5	72	hr	1334	1031	4033	0.2560	-0.1490
BT-20	Foretinib	3.33	uM	LJP5	72	hr	1334	1038	4033	0.2576	-0.1456
BT-20	Foretinib	10	uM	LJP5	72	hr	1334	820	4033	0.2034	-0.2632
BT-20	AZD 5438	0.04	uM	LJP6	72	hr	1334	3748	3925	0.9549	0.9405
BT-20	AZD 5438	0.12	uM	LJP6	72	hr	1334	3323	3925	0.8465	0.7965
BT-20	AZD 5438	0.37	uM	LJP6	72	hr	1334	2710	3925	0.6903	0.5760
BT-20	AZD 5438	1.11	uM	LJP6	72	hr	1334	1736	3925	0.4423	0.1829
BT-20	AZD 5438	3.33	uM	LJP6	72	hr	1334	1019	3925	0.2595	-0.1601
BT-20	AZD 5438	10	uM	LJP6	72	hr	1334	407	3925	0.1038	-0.5342
BT-20	Pelitinib	0.04	uM	LJP5	72	hr	1334	3996	4033	0.9906	0.9880
BT-20	Pelitinib	0.12	uM	LJP5	72	hr	1334	3802	4033	0.9427	0.9271
BT-20	Pelitinib	0.37	uM	LJP5	72	hr	1334	3297	4033	0.8178	0.7632
BT-20	Pelitinib	1.11	uM	LJP5	72	hr	1334	3080	4033	0.7632	0.6873

|<
<<
Previous
Page 106 of 166
Next
>>
>
2626 to 2650 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)